XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Redeemable Noncontrolling Interests -- Operating Partnership
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Dividends in Excess of Earnings
Accumulated other comprehensive income (loss), net
Interest Rate Swap
Accumulated other comprehensive income (loss), net
Total Noncontrolling Interests
Interest Rate Swap
Total Noncontrolling Interests
Interest Rate Swap
Total
Beginning balance at Dec. 31, 2020 $ 42,011 $ 950,940 $ 2,788 $ 20,626,897 $ (3,997,938)   $ 135,010   $ 728,639   $ 18,446,336
Beginning balance (shares) at Dec. 31, 2020     280,289,726                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of common units to common stock     $ 6 53,607         (53,613)    
Conversion of common units to common stock (shares)     642,190                
Common stock and share-based awards issued in connection with InterXion combination     $ 1 18,269             18,270
Common stock and share-based awards issued in connection with InterXion combination (in shares)     125,395                
Payment of offering costs and other       (232)             (232)
Shares issued under employee stock purchase plan       3,427             3,427
Shares issued under employee stock purchase plan (shares)     29,475                
Amortization of share-based compensation       28,788             28,788
Vesting of restricted stock, net (shares)     285,524                
Shares repurchased and retired to satisfy tax withholding upon vesting       (9,718)             (9,718)
Reclassification of vested share-based awards       (20,548)         20,548    
Adjustment to redeemable noncontrolling interests 208     (208)             (208)
Dividends declared on preferred stock         (13,514)           (13,514)
Dividends and distributions on common stock and common and incentive units (181)       (326,965)       (8,701)   (335,666)
Contributions from (distributions to) noncontrolling interests in consolidated entities (2,150)               31,680   31,680
Net income (loss) 209       385,920       8,547   394,467
Other comprehensive income (loss)-foreign currency translation adjustments             (213,471)   (5,531)   (219,002)
Other comprehensive income (loss)-fair value of interest rate swaps           $ 328   $ 9   $ 337 337
Other comprehensive income- reclassification of accumulated other comprehensive income/loss to interest expense             350   9   359
Ending balance at Mar. 31, 2021 40,097 950,940 $ 2,795 20,700,282 (3,952,497)   (77,783)   721,587   18,345,324
Ending balance (shares) at Mar. 31, 2021     281,372,310                
Beginning balance at Dec. 31, 2020 42,011 950,940 $ 2,788 20,626,897 (3,997,938)   135,010   728,639   18,446,336
Beginning balance (shares) at Dec. 31, 2020     280,289,726                
Ending balance at Dec. 31, 2021 46,995 731,690 $ 2,824 21,075,863 (3,631,929)   (173,880)   472,219   18,476,787
Ending balance (shares) at Dec. 31, 2021     284,415,013                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of common units to common stock       1,258         (1,258)    
Conversion of common units to common stock (shares)     14,861                
Issuance of common units in connection with acquisition (shares)     194,020                
Payment of offering costs and other       (4,024)             (4,024)
Shares issued under employee stock purchase plan       4,969             4,969
Shares issued under employee stock purchase plan (shares)     42,188                
Amortization of share-based compensation       18,545             18,545
Shares repurchased and retired to satisfy tax withholding upon vesting       (6,162)             (6,162)
Reclassification of vested share-based awards       (26,531)         26,531    
Adjustment to redeemable noncontrolling interests (5,473)     5,473             5,473
Dividends declared on preferred stock         (10,181)           (10,181)
Dividends and distributions on common stock and common and incentive units (190)       (348,025)       (7,786)   (355,811)
Contributions from (distributions to) noncontrolling interests in consolidated entities 1,367               17,559   17,559
Net income (loss) 35       73,281       3,594   76,875
Other comprehensive income (loss)-foreign currency translation adjustments             (13,551)   (326)   (13,877)
Other comprehensive income (loss)-fair value of interest rate swaps           $ (1,312)   $ (32)   $ (1,344) (1,344)
Other comprehensive income- reclassification of accumulated other comprehensive income/loss to interest expense             (101)   (2)   (103)
Ending balance at Mar. 31, 2022 $ 42,734 $ 731,690 $ 2,824 $ 21,069,391 $ (3,916,854)   $ (188,844)   $ 510,499   $ 18,208,706
Ending balance (shares) at Mar. 31, 2022     284,666,082